5:18 PM
 | 
Mar 12, 2012
 |  BC Extra  |  Financial News

Anthera plummets after discontinuing development of varespladib

Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) fell $2.86 (45%) to $3.56 on Monday after announcing late Friday that it will discontinue development of cardiovascular compound varespladib for all...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >